BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19375969)

  • 1. [Cell culture for transfusion purposes: the case of red blood cells].
    Douay L
    Transfus Clin Biol; 2009 May; 16(2):134-7. PubMed ID: 19375969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?
    Douay L; Andreu G
    Transfus Med Rev; 2007 Apr; 21(2):91-100. PubMed ID: 17397760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo generation of human red blood cells: a new advance in stem cell engineering.
    Douay L; Giarratana MC
    Methods Mol Biol; 2009; 482():127-40. PubMed ID: 19089353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From stem cell to red blood cells in vitro: "the 12 labors of Hercules".
    Douay L
    Clin Lab Med; 2010 Jun; 30(2):391-403. PubMed ID: 20513558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro generation of mature and functional human red blood cells: a model with multidisciplinary perspectives].
    Douay L; Giarratana MC
    Bull Acad Natl Med; 2005 May; 189(5):903-13; discussion 914-5. PubMed ID: 16433462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells--a source of adult red blood cells for transfusion purposes: present and future.
    Douay L; Lapillonne H; Turhan AG
    Crit Care Clin; 2009 Apr; 25(2):383-98, Table of Contents. PubMed ID: 19341915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells.
    Giarratana MC; Kobari L; Lapillonne H; Chalmers D; Kiger L; Cynober T; Marden MC; Wajcman H; Douay L
    Nat Biotechnol; 2005 Jan; 23(1):69-74. PubMed ID: 15619619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Red blood cell production for transfusion purposes. A stem cell ex vivo fate].
    Mazurier C; Douay L
    Transfus Clin Biol; 2013 May; 20(2):90-4. PubMed ID: 23601197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.
    Peyrard T; Bardiaux L; Krause C; Kobari L; Lapillonne H; Andreu G; Douay L
    Transfus Med Rev; 2011 Jul; 25(3):206-16. PubMed ID: 21377319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythroid cells in vitro: from developmental biology to blood transfusion products.
    Migliaccio AR; Whitsett C; Migliaccio G
    Curr Opin Hematol; 2009 Jul; 16(4):259-68. PubMed ID: 19444099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of hemoglobin-vesicles as artificial oxygen carriers.
    Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
    Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery.
    Fong J; Gurewitsch ED; Kang HJ; Kump L; Mack PF
    Anesth Analg; 2007 Mar; 104(3):666-72. PubMed ID: 17312227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex-vivo red blood cells generation: a step ahead in transfusion medicine?
    Lippi G; Montagnana M; Franchini M
    Eur J Intern Med; 2011 Feb; 22(1):16-9. PubMed ID: 21238887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for the manufacture of red cells for transfusion.
    Mountford J; Olivier E; Turner M
    Br J Haematol; 2010 Apr; 149(1):22-34. PubMed ID: 20151974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red cell freezing and its impact on the supply chain.
    Hess JR
    Transfus Med; 2004 Feb; 14(1):1-8. PubMed ID: 15043586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.
    Zeuner A; Martelli F; Vaglio S; Federici G; Whitsett C; Migliaccio AR
    Stem Cells; 2012 Aug; 30(8):1587-96. PubMed ID: 22644674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proof of principle for transfusion of in vitro-generated red blood cells.
    Giarratana MC; Rouard H; Dumont A; Kiger L; Safeukui I; Le Pennec PY; François S; Trugnan G; Peyrard T; Marie T; Jolly S; Hebert N; Mazurier C; Mario N; Harmand L; Lapillonne H; Devaux JY; Douay L
    Blood; 2011 Nov; 118(19):5071-9. PubMed ID: 21885599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured blood versus donated blood: long-run perspectives of the economy of blood.
    Mercier Ythier J
    Biomed Mater Eng; 2015; 25(1 Suppl):199-209. PubMed ID: 25538070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility study of hemoglobin vesicles, cellular-type artificial oxygen carriers, with human umbilical cord hematopoietic stem/progenitor cells using an in vitro expansion system.
    Yamaguchi M; Fujihara M; Wakamoto S; Sakai H; Takeoka S; Tsuchida E; Hamada H; Azuma H; Ikeda H
    ASAIO J; 2009; 55(3):200-5. PubMed ID: 19282747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.